ISO/TC 194
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 84512 | ISO 10993-1:2025 | Biological evaluation of medical devices — Part 1: Requirements and general principles for the evaluation of biological safety within a risk management process | Standarts spēkā |
| 86862 | ISO 10993-4:2017/Amd 1:2025 | Biological evaluation of medical devices — Part 4: Selection of tests for interactions with blood — Amendment 1 | Standarts spēkā |
| 71514 | ISO/TS 21726:2019 | Biological evaluation of medical devices — Application of the threshold of toxicological concern (TTC) for assessing biocompatibility of medical device constituents | Standarts spēkā |
| 88200 | ISO 10993-23:2021/Amd 1:2025 | Biological evaluation of medical devices — Part 23: Tests for irritation — Amendment 1: Additional in vitro reconstructed human epidermis models | Standarts spēkā |
| 88201 | ISO 10993-17:2023/Amd 1:2025 | Biological evaluation of medical devices — Part 17: Toxicological risk assessment of medical device constituents — Amendment 1 | Standarts spēkā |
| 75279 | ISO 10993-10:2021 | Biological evaluation of medical devices — Part 10: Tests for skin sensitization | Standarts spēkā |
| 68937 | ISO 10993-15:2019 | Biological evaluation of medical devices — Part 15: Identification and quantification of degradation products from metals and alloys | Standarts spēkā |
| 64887 | ISO/TR 37137:2014 | Cardiovascular biological evaluation of medical devices — Guidance for absorbable implants | Standarts spēkā |
| 88205 | ISO 10993-12:2021/Amd 1:2025 | Biological evaluation of medical devices — Part 12: Sample preparation and reference materials — Amendment 1 | Standarts spēkā |
| 65052 | ISO/TR 10993-33:2015 | Biological evaluation of medical devices — Part 33: Guidance on tests to evaluate genotoxicity — Supplement to ISO 10993-3 | Standarts spēkā |
Displaying 141-150 of 156 results.
